Ryunosuke Machida - Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 103 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety and Efficacy of Conversion Therapy for Metastatic Esophageal Cancer: Exploratory Analysis of JCOG1314

Satoru Matsuda,Hirofumi Kawakubo,Takahiro Tsushima,Shuichi Hironaka,Yasuhiro Tsubosa,Katsuyuki Sakanaka,Junya Oguma,Shigenori Kadowaki,Shigeru Tsunoda,Hiroki Hara,Kazuo Koyanagi,Toshifumi Yamaguchi,Kazuaki Harada,Masanobu Takahashi,Keiko Minashi, Eishi Baba,Keita Sasaki,Ryunosuke Machida,Hiroya Takeuchi

Journal of Clinical Oncologyno. 4_suppl (2025): 401-401

Cited0Views0Bibtex

Randomized Phase III Study Comparing Re-Irradiation Stereotactic Body Radiotherapy and Conventional Radiotherapy for Painful Spinal Metastases: Japan Clinical Oncology Group Study JCOG2211 (RESCORE Study)

Ryosuke Kita,Kei Ito,Ryunosuke Machida,Yuta Sekino,Naoki Nakamura,Yujiro Nakajima,Tetsuo Saito,Nobuki Imano,Haruhiko Fukuda,Yoshinori Ito,Takashi Mizowaki

Japanese journal of clinical oncologyno. 2 (2025): 189-193

Cited0Views0WOSBibtex

Impact of Time to Surgery on Outcomes in Patients with Advanced Esophageal Squamous Cell Carcinoma Following Neoadjuvant Therapy: an Exploratory Analysis of Phase III Trial JCOG1109

Ryosuke Kita,Ken Kato,Ryunosuke Machida,Yoshinori Ito,Hiroyuki Daiko,Hirofumi Kawakubo,Keita Sasaki,Haruhiko Fukuda, Yasue Kimura,Kohei Akiyoshi,Kazuo Koyanagi,Hiroki Hara,Keiko Minashi,Kenji Amagai,Tetsuya Abe,Hiroya Takeuchi

Journal of Clinical Oncologyno. 4_suppl (2025): 458-458

Cited0Views0Bibtex

Hiroshi Imazeki,Ken Kato,Yoshinori Ito,Hiroyuki Daiko,Keisho Chin,Kazuo Koyanagi,Takashi Ogata,Hiroki Hara,Takeo Fujita,Tetsuya Abe,Fumitaka Endo,Shigeru Tsunoda,Atsushi Takeno,Yoshiaki Nagatani,Hisayuki Matsushita,Hiroshi Sato,Satoru Matsuda, Kota Kawabata,Ryunosuke Machida,Hiroya Takeuchi

Journal of Clinical Oncologyno. 4_suppl (2025): 434-434

Cited0Views0Bibtex

Status of Incremental Costs of First-Line Treatment Recommended in Japanese Clinical Guidelines for Metastatic Breast Cancer Patients

Tsuguo Iwatani,Keita Sasaki,Ryunosuke Machida,Tadahiko Shien,Fumikata Hara,Tomomi Fujisawa,Yuko Takano,Yoshie Kobayashi,Michiyo Saimura,Kei Koizumi,Mitsuo Terada,Shinsuke Sasada,Kanako Saito, Miwa Sumiyoshi,Hiroji Iwata

JAPANESE JOURNAL OF CLINICAL ONCOLOGYno. 10 (2024): 1093-1099

Cited0Views0WOSBibtex

Upfront Allo-Hsct after Intensive Chemotherapy for Untreated Aggressive ATL: JCOG0907, a Single-Arm, Phase 3 Trial

Journal of Clinical Oncologyno. 16_suppl (2024): 7001-7001

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn